Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-23-018571
Date:2023-03-14
Issuer: CRISPR THERAPEUTICS AG (CRSP)
Original Submission Date:

Reporting Person:

PRASAD RAJU
C/O CRISPR THERAPEUTICS, INC.
105 WEST FIRST STREET BOSTON, MA 02127

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
RESTRICTED STOCK UNITS 0.0 2023-03-14 deemed execution date A 40,000 (a) common shares 40,000 $0.00 40,000 direct
STOCK OPTION (RIGHT TO BUY) 45.15 2023-03-14 deemed execution date A 100,000 (a) 2033-03-14 common shares 100,000 $45.15 100,000 direct
Footnotes
IDfootnote
f1 each restricted stock unit represents a contingent right to receive one share of crsp common shares.
f2 this restricted stock unit award was granted on march 14, 2023 with respect to 40,000 common shares, with (i) one quarter of the shares vesting on march 14, 2024, (ii) one quarter of the shares vesting on march 14, 2025, (iii) one quarter of the shares vesting on march 14, 2026, and (iv) one quarter of the shares vesting on march 14, 2027.
f3 this option was granted on march 14, 2023 with respect to 100,000 common shares, with 25% of the shares vesting on march 14, 2024 and the remaining shares vesting on each monthly anniversary thereafter for a period of 36 months.

Elevate your investments